Medtronic (NYSE:MDT – Get Free Report) had its target price raised by equities researchers at Robert W. Baird from $90.00 to $91.00 in a note issued to investors on Wednesday,Benzinga reports. The ...

Medtronic plc (NYSE:MDT – Get Free Report) shares were up 0.3% on Thursday after UBS Group raised their price target on the stock from $85.00 to $95.00. UBS Group currently has a neutral rating on the ...

They envision these devices working together to monitor our vital functions ... the medical device giant Medtronic introduced pacemakers and defibrillators that communicate wirelessly via its ...

The action, tied to two deaths, is among the latest in a surge of recalls by the agency, with nearly 100 Class I recalls in ...

The global Medical Device Contract Manufacturing market size was $73.61 billion in 2023 and is projected to reach $81.19 ...

Heart disease, also called cardiovascular disease, can have serious consequences. It's the leading cause of death for adults in the U.S. Medical devices approved by the U.S. Food and Drug ...

The first-ever pacemaker to include Managed Ventricular Pacing (MVP®), the EnRhythm™ Pacing System promotes intrinsic conduction and is clinically proven to significantly reduce unnecessary ...

The worldwide use of both magnetic resonance imaging (MRI) and pacing devices has vastly increased ... in patients with selected implantable pacemakers, MRI in pacemaker patients is still ...

Background: To determine the sensitivity and specificity, rate of compliance, and predictors of failure of telephone transmission of pacemaker function in a pediatric population. Methods ...